Aberrant Expression of Cortactin in Head and Neck Squamous Cell Carcinoma Cells Is Associated With Enhanced Cell Proliferation and Resistance to the Epidermal Growth Factor Receptor Inhibitor Gefitinib

Cancer Research - United States

doi 10.1158/0008-5472.can-07-0798